2020-05-28

Chairman at the Two Sessions | Li Zhenguo: Strengthening the nation starts with revitalizing Traditional Chinese Medicine!

Currently, the inheritance, innovation, and development of Traditional Chinese Medicine (TCM) have been elevated to a national strategy. Particularly during the recent fight against the pandemic, as evidenced by the multiple versions of clinical treatment guidelines issued by the state, TCM and its herbal remedies have demonstrated remarkable effectiveness in boosting the body's immune system, alleviating fever symptoms, controlling disease progression, and reducing complications—thus playing a positive role in the prevention and treatment of COVID-19. In light of this, Li Zhenguo, a National People's Congress delegate and Chairman of Jiuzhitang Co., Ltd., has put forward a proposal at this year's Two Sessions: to comprehensively revitalize the TCM sector!

2020-05-21

Delegates Discuss National Affairs | Representative Li Zhenguo: Traditional Chinese Medicine Requires Multi-Pronged Efforts for Heritage and Innovation

According to Representative Li Zhenguo, traditional medicine and precision medicine share common ground—after all, the core principles of TCM, such as "treating the same disease with different methods," "treating different diseases with the same method," and "diagnosing and treating based on syndrome differentiation," essentially embody the essence of precision medicine. He suggests that the nation should encourage traditional medicine and precision medicine to leverage their respective strengths, fostering a dynamic synergy between the two fields. Additionally, he urges medical institutions to embrace new technologies and innovative models, enabling the integrated application of traditional and precision medicine—and ultimately enhancing China's capacity to tackle critical illnesses.

2020-05-19

The master plan for the Daxing Biopharmaceutical Industry Base has been unveiled—Jiuzhitang Maker has already been included in the Daxing government's development plans!

On May 16, during the "Beijing Daxing District Key Industrial Parks Cloud Promotion Event" hosted by the Daxing Industry Promotion Association, the detailed plan for the Daxing Biomedical Base was unveiled for the first time. Notably, Jiuzhitang Maker has already been included in the Daxing government's development plans. The plan not only outlines the northward and southward expansion of the industrial zone, along with coordinated growth initiatives linking it to Daxing's western area, but also introduces groundbreaking updates such as the southern extension of Line 9 and the proposed site selection for Capital Medical University.

2020-05-18

[Performing Duties This Year] National People's Congress Deputy Li Zhenguo: Fulfilling Responsibilities on the Frontline of COVID-19 Response

"When the fight against the pandemic calls, Jiuzhitang cannot be absent," said Representative Li Zhenguo. As a pharmaceutical company with a 370-year history of traditional Chinese medicine development, Jiuzhitang upholds the philosophy that "a pharmacist must dedicate their full effort, and a physician should always act with integrity." Therefore, Jiuzhitang should actively embrace its social responsibility.

2020-05-15

Boxing legend Tyson reveals he’s been helped by stem-cell therapy, saying, "I feel like a whole new person!"

Boxing legend Tyson revealed he’s been helped by stem-cell therapy, saying, "I feel like a completely different person—but I can’t quite put my finger on why. It’s absolutely mind-blowing what scientists are capable of doing."

2020-05-13

Big news! Jiuzhitang and Youbo once again make it onto the Brand Value List!

At the "2020 China Brand Value Evaluation Information Online Launch Event," Jiuzhitang once again ranked among the top contenders on the "Time-Honored Chinese Brands" list, boasting a brand value of 10.316 billion yuan and a brand strength score of 917. Meanwhile, Jiuzhitang's subsidiary, Youbo Pharmaceutical, once again made it onto the "Pharmaceutical & Healthcare List," achieving a brand value of 4.732 billion yuan and a brand strength of 879.

2020-04-28

Jiuzhitang successfully passed the acceptance of the national pilot project for a new smart manufacturing model, actively promoting the high-quality development of the traditional Chinese medicine industry.

Nine Fortune Pharmaceutical has successfully passed the acceptance check for the national pilot project on a new intelligent manufacturing model. Moving forward, Nine Fortune Pharmaceutical will actively develop demonstration projects, driving the nation’s smart manufacturing initiative and rolling out intelligent manufacturing solutions across various regions for wider adoption and implementation.

2020-04-16

CCTV reports: Stem cell therapy combined with other treatment methods saves the life of a 60-year-old patient!

We believe that, with the joint efforts of our expert team, stem cells will further unlock their medical potential and contribute even more to the fight against the COVID-19 pandemic!

2020-04-02

Exploring stem cell therapy for autism: Lighting up the world for "children of the stars"!

April 2, 2020, marked the 13th World Autism Awareness Day, with the Chinese Association for Mental Health setting the theme as "Extra Care, Extra Attention." Beyond reminding everyone to foster mutual respect, understanding, and care between individuals with autism and the general population, this day also serves as an opportunity to reflect on and strengthen our own moral values and social responsibilities.